Shanghai Model Organisms Center Inc
SSE:688265
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 5-Year Average (40.5), the stock would be worth ¥39.25 (5% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 42.7 | ¥41.4 |
0%
|
| 5-Year Average | 40.5 | ¥39.25 |
-5%
|
| Industry Average | 34.5 | ¥33.41 |
-19%
|
| Country Average | 29.6 | ¥28.71 |
-31%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
S
|
Shanghai Model Organisms Center Inc
SSE:688265
|
2.1B CNY | 42.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
936.1B USD | 3 881 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
178B USD | 26 | |
| US |
|
Danaher Corp
NYSE:DHR
|
126.6B USD | 34.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 46.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
326.9B CNY | 17.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.9B CHF | -119.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 25.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.3B USD | 47.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
26.9B USD | 19.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26B USD | 29.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
Shanghai Model Organisms Center Inc
Glance View
Shanghai Model Organisms Center, Inc. provides life science research and drug discovery services for cancer immunotherapy. The company is headquartered in Shanghai, Shanghai and currently employs 509 full-time employees. The company went IPO on 2021-12-28. The firm's businesses include genetically modified animal model, model breeding, feeding service, efficacy evaluation and phenotypic analysis, other model biotechnology services, model purchase and sales business and other businesses. The genetically modified animal model products are divided into customized models and standardized models, mainly including genetically modified mouse models, genetically modified rat models, genetically modified nematode models and genetically modified zebrafish models. The model breeding business refers to the use of genetically modified animal models developed and produced by the issuer or existing genetically modified animal models provided by customers through natural breeding or assisted reproductive breeding.
